IMMUNIC, INC. — Director's Dealing 2015

Jan 29, 2015

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2014-12-31

Reporting Person: Winters Terence E. (Director, Co-Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-29	Common Stock	G	3240	$0.00	Disposed	182136	Direct

Footnotes

F1: The reported dispositions represent gifts of shares to family members. The gifted shares remain subject to lock-up agreements with the issuer pursuant to which the transferees agreed, subject to certain exceptions, not to dispose of or hedge any of these shares through the second full trading day following the date of issuance of a press release that includes topline data from Vital Therapies' VTI-208 Phase 3 clinical trial, except with the prior written consent of the issuer's board of directors. The reporting person disclaims any direct or indirect beneficial ownership in the gifted shares.